Lecanemab Clears Amyloid via Microglia and Fc Receptors
A 2026 Nature Neuroscience study found that lecanemab cleared amyloid in a humanized-microglia Alzheimer’s disease model only when microglia and the antibody’s intact Fc fragment were both p…
Read article